Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 238.00 | 231.00 | 1.0303 | 1.0338 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 156.25 | 67.09 | 285.00 | 231.00 | 1.2338 | 1.2500 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 156.25 | 67.09 | 395.00 | 231.00 | 1.7100 | 1.7018 |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 389.00 | 231.00 | 1.6840 | 1.6787 |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 437.00 | 231.00 | 1.8918 | 1.8592 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 156.25 | 67.09 | 336.00 | 231.00 | 1.4545 | 1.4675 |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 156.25 | 67.09 | 385.00 | 231.00 | 1.6667 | 1.6632 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 156.25 | 67.09 | 316.00 | 231.00 | 1.3680 | 1.3841 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 367.00 | 231.00 | 1.5887 | 1.5927 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 364.00 | 231.00 | 1.5758 | 1.5808 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 270.00 | 231.00 | 1.1688 | 1.1828 |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 156.25 | 67.09 | 260.00 | 231.00 | 1.1255 | 1.1371 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 156.25 | 67.09 | 262.00 | 231.00 | 1.1342 | 1.1463 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 156.25 | 67.09 | 246.00 | 231.00 | 1.0649 | 1.0718 |
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 156.25 | 67.09 | 138.00 | 231.00 | 0.5974 | 0.4983 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 170.00 | 231.00 | 0.7359 | 0.6841 | |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 424.00 | 507.00 | 0.8363 | 0.8348 | |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 312.50 | 120.45 | 554.00 | 507.00 | 1.0927 | 1.0874 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 312.50 | 120.45 | 774.00 | 507.00 | 1.5266 | 1.4527 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 611.00 | 507.00 | 1.2051 | 1.1883 | |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 312.50 | 120.45 | 278.00 | 507.00 | 0.5483 | 0.4968 |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 312.50 | 120.45 | 538.00 | 507.00 | 1.0611 | 1.0581 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 312.50 | 120.45 | 785.00 | 507.00 | 1.5483 | 1.4694 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 312.50 | 120.45 | 874.00 | 507.00 | 1.7239 | 1.6007 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 312.50 | 120.45 | 855.00 | 507.00 | 1.6864 | 1.5733 |